Platelet Function in Pre-Eclampsia

 

 Buy Article Permissions and Reprints

ABSTRACT

Pronounced hemostatic changes occur during pregnancy, and the balance shifts markedly in favor of hypercoagulability. Although primarily a result of a marked rise in the levels of several procoagulants and a fall in some natural anticoagulants, platelet activation also contributes to this prothrombotic tendency. Several studies have confirmed the accentuation of platelet activation in pre-eclampsia (P-EC), which remains an important obstetric complication affecting ~2 to 4% of pregnancies. Although there is still a long way to go, significant inroads have been made in the understanding of this enigmatic condition. Whereas the pathogenesis of P-EC is protean and involves a complex interplay of placental and maternal tissues, platelet activation is likely to contribute to several clinical features. Several techniques have been used to assess platelet activation in P-EC. Detection of aberrations of platelet function and activation appear to have predictive value for its diagnosis. The findings also lend support to the use of antiplatelet agents as prophylaxis in those women with a high risk of developing the condition.

REFERENCES

• 1 Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy . Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy.  Am J Obstet Gynecol. 2000;  183 (1) S1-S22
  CrossrefPubMedGoogle Scholar
• 2 American College of Obstetricians and Gynecologists .Hypertension in Pregnancy. ACOG Technical Bulletin No. 219. Washington, DC: The College; 1996: 1-8
  Google Scholar
• 3 Khan K S, Wojdyla D, Say L, Gülmezoglu A M, Van Look P F. WHO analysis of causes of maternal death: a systematic review.  Lancet. 2006;  367 (9516) 1066-1074
  CrossrefPubMedGoogle Scholar
• 4 Sibai B, Dekker G, Kupferminc M. Pre-eclampsia.  Lancet. 2005;  365 (9461) 785-799
  CrossrefPubMedGoogle Scholar
• 5 Roberts J M, Taylor R N, Musci T J, Rodgers G M, Hubel C A, McLaughlin M K. Preeclampsia: an endothelial cell disorder.  Am J Obstet Gynecol. 1989;  161 (5) 1200-1204
  CrossrefPubMedGoogle Scholar
• 6 Redman C W, Sacks G P, Sargent I L. Preeclampsia: an excessive maternal inflammatory response to pregnancy.  Am J Obstet Gynecol. 1999;  180 (2 Pt 1) 499-506
  CrossrefPubMedGoogle Scholar
• 7 Roberts J M, Taylor R N, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia.  Am J Hypertens. 1991;  4 (8) 700-708
  PubMedGoogle Scholar
• 8 Szecsi P B, Jørgensen M, Klajnbard A, Andersen M R, Colov N P, Stender S. Haemostatic reference intervals in pregnancy.  Thromb Haemost. 2010;  103 (4) 718-727
  Article in Thieme ConnectPubMedGoogle Scholar
• 9 Holthe M R, Staff A C, Berge L N, Lyberg T. Different levels of platelet activation in preeclamptic, normotensive pregnant, and nonpregnant women.  Am J Obstet Gynecol. 2004;  190 (4) 1128-1134
  CrossrefPubMedGoogle Scholar
• 10 Sill P R, Lind T, Walker W. Platelet values during normal pregnancy.  Br J Obstet Gynaecol. 1985;  92 (5) 480-483
  PubMedGoogle Scholar
• 11 Sejeny S A, Eastham R D, Baker S R. Platelet counts during normal pregnancy.  J Clin Pathol. 1975;  28 (10) 812-813
  CrossrefPubMedGoogle Scholar
• 12 Ahmed Y, van Iddekinge B, Paul C, Sullivan H F, Elder M G. Retrospective analysis of platelet numbers and volumes in normal pregnancy and in pre-eclampsia.  Br J Obstet Gynaecol. 1993;  100 (3) 216-220
  PubMedGoogle Scholar
• 13 Rinder H M, Bonan J L, Anandan S, Rinder C S, Rodrigues P A, Smith B R. Noninvasive measurement of platelet kinetics in normal and hypertensive pregnancies.  Am J Obstet Gynecol. 1994;  170 (1 Pt 1) 117-122
  PubMedGoogle Scholar
• 14 Milman N, Bergholt T, Byg K E, Eriksen L, Hvas A M. Reference intervals for haematological variables during normal pregnancy and postpartum in 434 healthy Danish women.  Eur J Haematol. 2007;  79 (1) 39-46
  CrossrefPubMedGoogle Scholar
• 15 Fay R A, Hughes A O, Farron N T. Platelets in pregnancy: hyperdestruction in pregnancy.  Obstet Gynecol. 1983;  61 (2) 238-240
  PubMedGoogle Scholar
• 16 Rabini R A, Salvolini E, Staffolani R et al. Biochemical-morphological modifications of platelet membranes during pregnancy-induced hypertension.  Exp Mol Pathol. 1995;  63 (3) 175-185
  CrossrefPubMedGoogle Scholar
• 17 Damron D P, Bouchard B A, Shapiro R E, Schonberg A L, Bernstein I M. Platelet activation, sympathetic tone, and plasma volume in nulligravid women of reproductive age.  Obstet Gynecol. 2004;  103 (5 Pt 1) 931-936
  CrossrefPubMedGoogle Scholar
• 18 Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension.  Thromb Haemost. 1985;  54 (3) 607-611
  PubMedGoogle Scholar
• 19 Sheu J R, Hsiao G, Shen M Y, Lin W Y, Tzeng C R. The hyperaggregability of platelets from normal pregnancy is mediated through thromboxane A2 and cyclic AMP pathways.  Clin Lab Haematol. 2002;  24 (2) 121-129
  CrossrefPubMedGoogle Scholar
• 20 Hayashi M, Kiumi F, Mitsuya K. Changes in platelet ATP secretion and aggregation during pregnancy and in preeclampsia.  Am J Med Sci. 1999;  318 (2) 115-121
  CrossrefPubMedGoogle Scholar
• 21 Gerbasi F R, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy.  Obstet Gynecol. 1990;  75 (3 Pt 1) 385-389
  PubMedGoogle Scholar
• 22 Jungi T W, Spycher M O, Nydegger U E, Barandun S. Platelet-leukocyte interaction: selective binding of thrombin-stimulated platelets to human monocytes, polymorphonuclear leukocytes, and related cell lines.  Blood. 1986;  67 (3) 629-636
  PubMedGoogle Scholar
• 23 Sarma J, Laan C A, Alam S, Jha A, Fox K A, Dransfield I. Increased platelet binding to circulating monocytes in acute coronary syndromes.  Circulation. 2002;  105 (18) 2166-2171
  CrossrefPubMedGoogle Scholar
• 24 Kageyama K, Nakajima Y, Shibasaki M, Hashimoto S, Mizobe T. Increased platelet, leukocyte, and endothelial cell activity are associated with increased coagulability in patients after total knee arthroplasty.  J Thromb Haemost. 2007;  5 (4) 738-745
  CrossrefPubMedGoogle Scholar
• 25 Robb A O, Din J N, Mills N L et al. The influence of the menstrual cycle, normal pregnancy and pre-eclampsia on platelet activation.  Thromb Haemost. 2010;  103 (2) 372-378
  Article in Thieme ConnectPubMedGoogle Scholar
• 26 Henn V, Slupsky J R, Gräfe M et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells.  Nature. 1998;  391 (6667) 591-594
  Google Scholar
• 27 Henn V, Steinbach S, Büchner K, Presek P, Kroczek R A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40.  Blood. 2001;  98 (4) 1047-1054
  CrossrefPubMedGoogle Scholar
• 28 Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia.  Obstet Gynecol. 2006;  107 (4) 896-900
  CrossrefPubMedGoogle Scholar
• 29 Darmochwal-Kolarz D, Kolarz B, Surdacka A, Rolinski J, Leszczynska-Gorzelak B, Oleszczuk J. The expression and concentration of CD40 ligand in normal pregnancy and pre-eclampsia.  J Reprod Immunol. 2009;  79 (2) 215-219
  CrossrefPubMedGoogle Scholar
• 30 Heilmann L, Rath W, Pollow K. Hemostatic abnormalities in patients with severe preeclampsia.  Clin Appl Thromb Hemost. 2007;  13 (3) 285-291
  CrossrefPubMedGoogle Scholar
• 31 Redman C W, Bonnar J, Beilin L. Early platelet consumption in pre-eclampsia.  BMJ. 1978;  1 (6111) 467-469
  CrossrefPubMedGoogle Scholar
• 32 Dundar O, Yoruk P, Tutuncu L et al. Longitudinal study of platelet size changes in gestation and predictive power of elevated MPV in development of pre-eclampsia.  Prenat Diagn. 2008;  28 (11) 1052-1056
  CrossrefPubMedGoogle Scholar
• 33 Howarth S, Marshall L R, Barr A L, Evans S, Pontre M, Ryan N. Platelet indices during normal pregnancy and pre-eclampsia.  Br J Biomed Sci. 1999;  56 (1) 20-22
  PubMedGoogle Scholar
• 34 Coata G, Frusca T, Baranzelli D, Cosmi E V, Di Renzo G C, Anceschi M M. Abnormal platelet lipid membrane composition in pregnancy induced hypertension.  J Perinat Med. 1992;  20 (2) 123-127
  CrossrefPubMedGoogle Scholar
• 35 Shang T, Qiao C. Study on the activity of platelets protein kinase C in patients with pregnancy induced hypertension.  [in Chinese] Zhonghua Fu Chan Ke Za Zhi. 1998;  33 (4) 201-203
  PubMedGoogle Scholar
• 36 Takeuchi T, Yoneyama Y, Suzuki S, Sawa R, Otsubo Y, Araki T. Regulation of platelet aggregation in vitro by plasma adenosine in preeclampsia.  Gynecol Obstet Invest. 2001;  51 (1) 36-39
  CrossrefPubMedGoogle Scholar
• 37 Socol M L, Weiner C P, Louis G, Rehnberg K, Rossi E C. Platelet activation in preeclampsia.  Am J Obstet Gynecol. 1985;  151 (4) 494-497
  PubMedGoogle Scholar
• 38 Mellembakken J R, Solum N O, Ueland T, Videm V, Aukrust P. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia—possible role of platelet activation.  Thromb Haemost. 2001;  86 (5) 1272-1276
  PubMedGoogle Scholar
• 39 Peraçoli M T, Menegon F T, Borges V T, de Araújo Costa R A, Thomazini-Santos I A, Peraçoli J C. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.  J Reprod Immunol. 2008;  79 (1) 79-84
  CrossrefPubMedGoogle Scholar
• 40 Louden K A, Broughton Pipkin F, Heptinstall S, Fox S C, Mitchell J R, Symonds E M. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia.  Br J Obstet Gynaecol. 1991;  98 (12) 1239-1244
  CrossrefPubMedGoogle Scholar
• 41 Norris L A, Gleeson N, Sheppard B L, Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia.  Br J Obstet Gynaecol. 1993;  100 (7) 684-688
  CrossrefPubMedGoogle Scholar
• 42 Nisell H, Grunewald C, Berglud M, Karlberg K E, Lunell N O, Sylven C. Platelet aggregation in vitro and ex vivo in normal pregnancy, pregnancy-induced hypertension and pre-eclampsia.  Hypertens Pregnancy. 1998;  17 (2) 147-155
  CrossrefPubMedGoogle Scholar
• 43 Lev P R, Salim J P, Marta R F, Osorio M J, Goette N P, Molinas F C. Platelets possess functional TGF-beta receptors and Smad2 protein.  Platelets. 2007;  18 (1) 35-42
  CrossrefPubMedGoogle Scholar
• 44 Janes S L, Kyle P M, Redman C, Goodall A H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia.  Thromb Haemost. 1995;  74 (4) 1059-1063
  PubMedGoogle Scholar
• 45 Konijnenberg A, van der Post J A, Mol B W et al. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study.  Am J Obstet Gynecol. 1997;  177 (2) 434-442
  CrossrefPubMedGoogle Scholar
• 46 Konijnenberg A, Stokkers E W, van der Post J A et al. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules.  Am J Obstet Gynecol. 1997;  176 (2) 461-469
  CrossrefPubMedGoogle Scholar
• 47 Harlow F H, Brown M A, Brighton T A et al. Platelet activation in the hypertensive disorders of pregnancy.  Am J Obstet Gynecol. 2002;  187 (3) 688-695
  CrossrefPubMedGoogle Scholar
• 48 Yoneyama Y, Suzuki S, Sawa R, Kiyokawa Y, Power G G, Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia.  Obstet Gynecol. 2001;  97 (3) 366-370
  CrossrefPubMedGoogle Scholar
• 49 Barnard M R, Linden M D, Frelinger III AL et al. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.  J Thromb Haemost. 2005;  3 (11) 2563-2570
  CrossrefPubMedGoogle Scholar
• 50 Macey M, McCarthy D, Azam U, Milne T, Golledge P, Newland A. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.  Cytometry B Clin Cytom. 2003;  51 (1) 30-40
  PubMedGoogle Scholar
• 51 Del Conde I, Shrimpton C N, Thiagarajan P, López J A. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.  Blood. 2005;  106 (5) 1604-1611
  CrossrefPubMedGoogle Scholar
• 52 Holthe M R, Lyberg T, Staff A C, Berge L N. Leukocyte-platelet interaction in pregnancies complicated with preeclampsia.  Platelets. 2005;  16 (2) 91-97
  CrossrefPubMedGoogle Scholar
• 53 Srinivas S K, Edlow A G, Neff P M, Sammel M D, Andrela C M, Elovitz M A. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension?.  J Perinatol. 2009;  29 (10) 680-684
  CrossrefPubMedGoogle Scholar
• 54 Kühne T, Ryan G, Blanchette V et al. Platelet-surface glycoproteins in healthy and preeclamptic mothers and their newborn infants.  Pediatr Res. 1996;  40 (6) 876-880
  CrossrefPubMedGoogle Scholar
• 55 Klein B, Faridi A, Amo-Takyi B K, Heilmann L, Von Tempelhoff G F, Rath W. Neonatal platelet activation in preeclampsia.  Clin Appl Thromb Hemost. 2001;  7 (1) 29-32
  CrossrefPubMedGoogle Scholar
• 56 Clark D A. Tolerance signaling molecules.  Chem Immunol Allergy. 2005;  89 36-48
  PubMedGoogle Scholar
• 57 Sato Y, Fujiwara H, Zeng B X, Higuchi T, Yoshioka S, Fujii S. Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries.  Blood. 2005;  106 (2) 428-435
  CrossrefPubMedGoogle Scholar
• 58 Falconer J, Pineo G, Blahey W, Bowen T, Docksteader B, Jadusingh I. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation.  Am J Hematol. 1987;  25 (3) 345-347
  CrossrefPubMedGoogle Scholar
• 59 Vantroyen B, Vanstraelen D. Management of essential thrombocythemia during pregnancy with aspirin, interferon alpha-2a and no treatment. A comparative analysis of the literature.  Acta Haematol. 2002;  107 (3) 158-169
  CrossrefPubMedGoogle Scholar

Rashid S KazmiM.R.C.P. F.R.C.Path. 

Department of Haematology, Southampton University Hospitals NHS Trust

Southampton, UK

Email: syed.kazmi@suht.swest.nhs.uk